Now livetag icon
AI created more apps than ever, but 75% won't make it. Find out how to win. Download the reportbanner icon
Numab

May 2026

Numab Market Share Analysis for May 2026

Numab Therapeutics AG
Industry: N/A
Domainnumab.com
Year Founded2011
Employees51 - 200
Annual Revenue$15M - $25M
numab.com
Numab
Numab (including company regionals)
  • numab.com
    numab.com
See more website traffic and engagement information

Numab Revenue up to May 2026 is 15M - 25M

revenue generated by Numab top domains

Numab top domains revenue over 3 years

Revenue for Numab top domains


Total visits to Numab's top domains

Understand Numab market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in Numab's top domains

Analyze Numab engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

Avg. pageviews on Numab's top domains

See how Numab keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.


Numab top competitors by domain

Top similar sites in May 2026, ranked by their affinity

Benchmark Your Digital Performance

Identify high-value opportunities, track your performance, and win your market.


Top technologies used by Numab

These are the website technologies, by industry, used by Numab top domains

Mobile (3)

Meta Viewport

Meta Viewport

Email Services (2)

Microsoft Exchange Online

Microsoft Exchange Online

Widget (2)

reCAPTCHA

reCAPTCHA

Advertising (1)

PubMatic

PubMatic

More Technologies

4

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from Numab

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsNumab AG partners with Boehringer Ingelheim.Numab Therapeutics achieves milestone in collaboration with Boehringer Ingelheim.
NewsNumab AG is developing multi-specific antibody-based immunotherapies.Numab Therapeutics AG is developing multi-specific antibody-based immunotherapies for inflammation and cancer.

See all Numab signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.